{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T21:00:29Z","timestamp":1790629229089,"version":"4.1.0"},"reference-count":69,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2021,6,9]],"date-time":"2021-06-09T00:00:00Z","timestamp":1623196800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,6,9]],"date-time":"2021-06-09T00:00:00Z","timestamp":1623196800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1007\/s12020-021-02770-6","type":"journal-article","created":{"date-parts":[[2021,6,9]],"date-time":"2021-06-09T14:21:44Z","timestamp":1623248504000},"page":"243-254","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":46,"title":["SARS-CoV-2 plays a pivotal role in inducing hyperthyroidism of Graves\u2019 disease"],"prefix":"10.1007","volume":"73","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3096-6100","authenticated-orcid":false,"given":"Avaniyapuram Kannan","family":"Murugan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali S.","family":"Alzahrani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,6,9]]},"reference":[{"issue":"2","key":"2770_CR1","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","volume":"181","author":"M Hoffmann","year":"2020","unstructured":"M. Hoffmann, H. Kleine-Weber, S. Schroeder, N. Kr\u00fcger, T. Herrler, S. Erichsen, T.S. Schiergens, G. Herrler, N.H. Wu, A. Nitsche, M.A. M\u00fcller, C. Drosten, S. P\u00f6hlmann, SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell 181(2), 271\u2013280.e8 (2020). https:\/\/doi.org\/10.1016\/j.cell.2020.02.052","journal-title":"Cell"},{"key":"2770_CR2","unstructured":"COVID-19 data portal home page. https:\/\/coronavirus.jhu.edu. Accessed on May 11, 2021."},{"issue":"5","key":"2770_CR3","doi-asserted-by":"publisher","first-page":"2000547","DOI":"10.1183\/13993003.00547-2020","volume":"55","author":"WJ Guan","year":"2020","unstructured":"W.J. Guan, W.H. Liang, Y. Zhao, H.R. Liang, Z.S. Chen, Y.M. Li, X.Q. Liu, R.C. Chen, C.L. Tang, T. Wang, C.Q. Ou, L. Li, P.Y. Chen, L. Sang, W. Wang, J.F. Li, C.C. Li, L.M. Ou, B. Cheng, S. Xiong, Z.Y. Ni, J. Xiang, Y. Hu, L. Liu, H. Shan, C.L. Lei, Y.X. Peng, L. Wei, Y. Liu, Y.H. Hu, P. Peng, J.M. Wang, J.Y. Liu, Z. Chen, G. Li, Z.J. Zheng, S.Q. Qiu, J. Luo, C.J. Ye, S.Y. Zhu, L.L. Cheng, F. Ye, S.Y. Li, J.P. Zheng, N.F. Zhang, N.S. Zhong, J.X. He, Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis. Eur. Respir. J. 55(5), 2000547 (2020). https:\/\/doi.org\/10.1183\/13993003.00547-2020","journal-title":"Eur. Respir. J."},{"issue":"1","key":"2770_CR4","doi-asserted-by":"publisher","DOI":"10.1186\/s40249-020-00662-x","volume":"9","author":"MY Li","year":"2020","unstructured":"M.Y. Li, L. Li, Y. Zhang, X.S. Wang, Expression of the SARS-CoV-2 cell receptor gene ACE2 in a wide variety of human tissues. Infect. Dis. Poverty 9(1), 45 (2020). https:\/\/doi.org\/10.1186\/s40249-020-00662-x","journal-title":"Infect. Dis. Poverty"},{"issue":"4","key":"2770_CR5","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1530\/EJE-20-0335","volume":"183","author":"A Lania","year":"2020","unstructured":"A. Lania, M.T. Sandri, M. Cellini, M. Mirani, E. Lavezzi, G. Mazziotti, Thyrotoxicosis in patients with COVID-19: the THYRCOV study. Eur. J. Endocrinol. 183(4), 381\u2013387 (2020). https:\/\/doi.org\/10.1530\/EJE-20-0335","journal-title":"Eur. J. Endocrinol."},{"issue":"10","key":"2770_CR6","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1007\/s40618-020-01366-7","volume":"43","author":"M Mateu-Salat","year":"2020","unstructured":"M. Mateu-Salat, E. Urgell, A. Chico, SARS-COV-2 as a trigger for autoimmune disease: report of two cases of Graves\u2019 disease after COVID-19. J. Endocrinol. Invest. 43(10), 1527\u20131528 (2020). https:\/\/doi.org\/10.1007\/s40618-020-01366-7","journal-title":"J. Endocrinol. Invest."},{"issue":"2","key":"2770_CR7","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1007\/s40618-020-01440-0","volume":"44","author":"S Jim\u00e9nez-Blanco","year":"2021","unstructured":"S. Jim\u00e9nez-Blanco, B. Pla-Peris, M. Marazuela, COVID-19: a cause of recurrent Graves\u2019 hyperthyroidism? J. Endocrinol. Invest. 44(2), 387\u2013388 (2021). https:\/\/doi.org\/10.1007\/s40618-020-01440-0","journal-title":"J. Endocrinol. Invest."},{"issue":"2","key":"2770_CR8","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1152\/physrev.00030.2013","volume":"94","author":"R Mullur","year":"2014","unstructured":"R. Mullur, Y.Y. Liu, G.A. Brent, Thyroid hormone regulation of metabolism. Physiol. Rev. 94(2), 355\u2013382 (2014). https:\/\/doi.org\/10.1152\/physrev.00030.2013","journal-title":"Physiol. Rev."},{"issue":"5","key":"2770_CR9","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1038\/nrendo.2018.18","volume":"14","author":"PN Taylor","year":"2018","unstructured":"P.N. Taylor, D. Albrecht, A. Scholz, G. Gutierrez-Buey, J.H. Lazarus, C.M. Dayan, O.E. Okosieme, Global epidemiology of hyperthyroidism and hypothyroidism. Nat. Rev. Endocrinol. 14(5), 301\u2013316 (2018). https:\/\/doi.org\/10.1038\/nrendo.2018.18","journal-title":"Nat. Rev. Endocrinol."},{"issue":"1","key":"2770_CR10","doi-asserted-by":"publisher","first-page":"101387","DOI":"10.1016\/j.beem.2020.101387","volume":"34","author":"A Antonelli","year":"2020","unstructured":"A. Antonelli, S.M. Ferrari, F. Ragusa, G. Elia, S.R. Paparo, I. Ruffilli, A. Patrizio, C. Giusti, D. Gonnella, A. Cristaudo, R. Foddis, Y. Shoenfeld, P. Fallahi, Graves\u2019 disease: epidemiology, genetic and environmental risk factors and viruses. Best. Pract. Res. Clin. Endocrinol. Metab. 34(1), 101387 (2020). https:\/\/doi.org\/10.1016\/j.beem.2020.101387","journal-title":"Best. Pract. Res. Clin. Endocrinol. Metab."},{"issue":"16","key":"2770_CR11","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.1056\/NEJMra1510030","volume":"375","author":"TJ Smith","year":"2016","unstructured":"T.J. Smith, L. Heged\u00fcs, Graves\u2019 disease. N. Engl. J. Med. 375(16), 1552\u20131565 (2016). https:\/\/doi.org\/10.1056\/NEJMra1510030","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"2770_CR12","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.aace.2020.12.005","volume":"7","author":"A Harris","year":"2021","unstructured":"A. Harris, M.A.L. Mushref, Graves\u2019 thyrotoxicosis following SARS-CoV-2 infection. AACE Clin. Case Rep. 7(1), 14\u201316 (2021). https:\/\/doi.org\/10.1016\/j.aace.2020.12.005","journal-title":"AACE Clin. Case Rep."},{"issue":"1","key":"2770_CR13","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1007\/s12020-014-0289-8","volume":"48","author":"R Vita","year":"2015","unstructured":"R. Vita, D. Lapa, F. Trimarchi, S. Benvenga, Stress triggers the onset and the recurrences of hyperthyroidism in patients with Graves\u2019 disease. Endocrine 48(1), 254\u2013263 (2015). https:\/\/doi.org\/10.1007\/s12020-014-0289-8","journal-title":"Endocrine"},{"issue":"5","key":"2770_CR14","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1530\/eje.0.1500605","volume":"150","author":"MF Prummel","year":"2004","unstructured":"M.F. Prummel, T. Strieder, W.M. Wiersinga, The environment and autoimmune thyroid diseases. Eur. J. Endocrinol. 150(5), 605\u2013618 (2004). https:\/\/doi.org\/10.1530\/eje.0.1500605","journal-title":"Eur. J. Endocrinol."},{"issue":"8","key":"2770_CR15","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1007\/s40618-020-01316-3","volume":"43","author":"E Asfuroglu Kalkan","year":"2020","unstructured":"E. Asfuroglu Kalkan, I. Ates, A case of subacute thyroiditis associated with Covid-19 infection. J. Endocrinol. Invest. 43(8), 1173\u20131174 (2020). https:\/\/doi.org\/10.1007\/s40618-020-01316-3","journal-title":"J. Endocrinol. Invest."},{"issue":"8","key":"2770_CR16","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1007\/s40618-020-01312-7","volume":"43","author":"S Ippolito","year":"2020","unstructured":"S. Ippolito, F. Dentali, M.L. Tanda, SARS-CoV-2: a potential trigger for subacute thyroiditis? Insights from a case report. J. Endocrinol. Invest. 43(8), 1171\u20131172 (2020). https:\/\/doi.org\/10.1007\/s40618-020-01312-7","journal-title":"J. Endocrinol. Invest."},{"issue":"7","key":"2770_CR17","doi-asserted-by":"publisher","first-page":"dgaa276","DOI":"10.1210\/clinem\/dgaa276","volume":"105","author":"A Brancatella","year":"2020","unstructured":"A. Brancatella, D. Ricci, N. Viola, D. Sgr\u00f2, F. Santini, F. Latrofa, Subacute thyroiditis after Sars-COV-2 infection. J. Clin. Endocrinol. Metab. 105(7), dgaa276 (2020). https:\/\/doi.org\/10.1210\/clinem\/dgaa276","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"8","key":"2770_CR18","doi-asserted-by":"publisher","first-page":"2976","DOI":"10.1210\/jcem.81.8.8768861","volume":"81","author":"M Salvi","year":"1996","unstructured":"M. Salvi, G. Girasole, M. Pedrazzoni, M. Passeri, N. Giuliani, R. Minelli, L.E. Braverman, E. Roti, Increased serum concentrations of interleukin-6 (IL-6) and soluble IL-6 receptor in patients with Graves\u2019 disease. J. Clin. Endocrinol. Metab. 81(8), 2976\u20132979 (1996). https:\/\/doi.org\/10.1210\/jcem.81.8.8768861","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"2770_CR19","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.cytogfr.2020.06.001","volume":"54","author":"VJ Costela-Ruiz","year":"2020","unstructured":"V.J. Costela-Ruiz, R. Illescas-Montes, J.M. Puerta-Puerta, C. Ruiz, L. Melguizo-Rodr\u00edguez, SARS-CoV-2 infection: the role of cytokines in COVID-19 disease. Cytokine Growth Factor Rev. 54, 62\u201375 (2020). https:\/\/doi.org\/10.1016\/j.cytogfr.2020.06.001","journal-title":"Cytokine Growth Factor Rev."},{"issue":"1-3","key":"2770_CR20","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1007\/s12026-012-8312-8","volume":"54","author":"SA Morshed","year":"2012","unstructured":"S.A. Morshed, R. Latif, T.F. Davies, Delineating the autoimmune mechanisms in Graves\u2019 disease. Immunol. Res. 54(1-3), 191\u2013203 (2012). https:\/\/doi.org\/10.1007\/s12026-012-8312-8","journal-title":"Immunol. Res."},{"issue":"3","key":"2770_CR21","doi-asserted-by":"publisher","first-page":"2204","DOI":"10.1002\/jcp.27180","volume":"234","author":"Q Li","year":"2019","unstructured":"Q. Li, B. Wang, K. Mu, J.A. Zhang, The pathogenesis of thyroid autoimmune diseases: New T lymphocytes - Cytokines circuits beyond the Th1-Th2 paradigm. J. Cell. Physiol. 234(3), 2204\u20132216 (2019). https:\/\/doi.org\/10.1002\/jcp.27180","journal-title":"J. Cell. Physiol."},{"key":"2770_CR22","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1196\/annals.1366.015","volume":"1088","author":"A Tsatsoulis","year":"2006","unstructured":"A. Tsatsoulis, The role of stress in the clinical expression of thyroid autoimmunity. Ann. N. Y. Acad. Sci. 1088, 382\u2013395 (2006). https:\/\/doi.org\/10.1196\/annals.1366.015","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"10","key":"2770_CR23","doi-asserted-by":"publisher","first-page":"4561","DOI":"10.1210\/en.2006-0507","volume":"147","author":"JA Gilbert","year":"2006","unstructured":"J.A. Gilbert, S.L. Kalled, J. Moorhead, D.M. Hess, P. Rennert, Z. Li, M.Z. Khan, J.P. Banga, Treatment of autoimmune hyperthyroidism in a murine model of Graves\u2019 disease with tumor necrosis factor-family ligand inhibitors suggests a key role for B cell activating factor in disease pathology. Endocrinology 147(10), 4561\u20134568 (2006). https:\/\/doi.org\/10.1210\/en.2006-0507","journal-title":"Endocrinology"},{"issue":"39","key":"2770_CR24","doi-asserted-by":"publisher","first-page":"14993","DOI":"10.1073\/pnas.0806044105","volume":"105","author":"Q Lai Kwan Lam","year":"2008","unstructured":"Q. Lai Kwan Lam, O. King Hung, Ko,B.J. Zheng, L. Lu, Local BAFF gene silencing suppresses Th17-cell generation and ameliorates autoimmune arthritis. Proc. Natl Acad. Sci. U. S. A 105(39), 14993\u201314998 (2008). https:\/\/doi.org\/10.1073\/pnas.0806044105","journal-title":"Proc. Natl Acad. Sci. U. S. A"},{"issue":"4","key":"2770_CR25","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1530\/eje.1.02119","volume":"154","author":"M Salvi","year":"2006","unstructured":"M. Salvi, G. Vannucchi, I. Campi, S. Rossi, P. Bonara, F. Sbrozzi, C. Guastella, S. Avignone, G. Pirola, R. Ratiglia, P. Beck-Peccoz, Efficacy of rituximab treatment for thyroid-associated ophthalmopathy as a result of intraorbital B-cell depletion in one patient unresponsive to steroid immunosuppression. Eur. J. Endocrinol. 154(4), 511\u2013517 (2006). https:\/\/doi.org\/10.1530\/eje.1.02119","journal-title":"Eur. J. Endocrinol."},{"issue":"5","key":"2770_CR26","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.1210\/en.2006-1754","volume":"148","author":"CR Chen","year":"2007","unstructured":"C.R. Chen, S.M. McLachlan, B. Rapoport, Suppression of thyrotropin receptor constitutive activity by a monoclonal antibody with inverse agonist activity. Endocrinology 148(5), 2375\u20132382 (2007). https:\/\/doi.org\/10.1210\/en.2006-1754","journal-title":"Endocrinology"},{"issue":"3","key":"2770_CR27","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1038\/nri750","volume":"2","author":"G Stassi","year":"2002","unstructured":"G. Stassi, R. De, Maria, Autoimmune thyroid disease: new models of cell death in autoimmunity. Nat. Rev. Immunol. 2(3), 195\u2013204 (2002). https:\/\/doi.org\/10.1038\/nri750","journal-title":"Nat. Rev. Immunol."},{"issue":"4","key":"2770_CR28","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1056\/NEJM199107253250404","volume":"325","author":"TF Davies","year":"1991","unstructured":"T.F. Davies, A. Martin, E.S. Concepcion, P. Graves, L. Cohen, A. Ben-Nun, Evidence of limited variability of antigen receptors on intrathyroidal T cells in autoimmune thyroid disease. N. Engl. J. Med. 325(4), 238\u2013244 (1991). https:\/\/doi.org\/10.1056\/NEJM199107253250404","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"2770_CR29","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1172\/JCI115556","volume":"89","author":"TF Davies","year":"1992","unstructured":"T.F. Davies, A. Martin, E.S. Concepcion, P. Graves, N. Lahat, W.L. Cohen, A. Ben-Nun, Evidence for selective accumulation of intrathyroidal T lymphocytes in human autoimmune thyroid disease based on T cell receptor V gene usage. J. Clin. Invest. 89(1), 157\u2013162 (1992). https:\/\/doi.org\/10.1172\/JCI115556","journal-title":"J. Clin. Invest."},{"issue":"16","key":"2770_CR30","doi-asserted-by":"publisher","first-page":"7415","DOI":"10.1073\/pnas.88.16.7415","volume":"88","author":"CM Dayan","year":"1991","unstructured":"C.M. Dayan, M. Londei, A.E. Corcoran, B. Grubeck-Loebenstein, R.F. James, B. Rapoport, M. Feldmann, Autoantigen recognition by thyroid-infiltrating T cells in Graves disease. Proc. Natl Acad. Sci. U. S. A. 88(16), 7415\u20137419 (1991). https:\/\/doi.org\/10.1073\/pnas.88.16.7415","journal-title":"Proc. Natl Acad. Sci. U. S. A."},{"issue":"2","key":"2770_CR31","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1210\/jcem-59-2-187","volume":"59","author":"RA Jackson","year":"1984","unstructured":"R.A. Jackson, B.F. Haynes, W.M. Burch, K. Shimizu, M.A. Bowring, G.S. Eisenbarth, Ia+ T cells in new onset Graves\u2019 disease. J. Clin. Endocrinol. Metab. 59(2), 187\u2013190 (1984). https:\/\/doi.org\/10.1210\/jcem-59-2-187","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"2770_CR32","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1210\/jcem-56-1-164","volume":"56","author":"JR Wall","year":"1983","unstructured":"J.R. Wall, R. Baur, H. Schleusener, P. Bandy-Dafoe, Peripheral blood and intrathyroidal mononuclear cell populations in patients with autoimmune thyroid disorders enumerated using monoclonal antibodies. J. Clin. Endocrinol. Metab. 56(1), 164\u2013169 (1983). https:\/\/doi.org\/10.1210\/jcem-56-1-164","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1-2","key":"2770_CR33","doi-asserted-by":"publisher","first-page":"111","DOI":"10.3109\/08830189909043021","volume":"18","author":"A Martin","year":"1999","unstructured":"A. Martin, G. Barbesino, T.F. Davies, T-cell receptors and autoimmune thyroid disease-signposts for T-cell-antigen driven diseases. Int. Rev. Immunol. 18(1-2), 111\u2013140 (1999). https:\/\/doi.org\/10.3109\/08830189909043021","journal-title":"Int. Rev. Immunol."},{"issue":"10","key":"2770_CR34","doi-asserted-by":"publisher","first-page":"3361","DOI":"10.1210\/jcem.82.10.4299","volume":"82","author":"A Martin","year":"1997","unstructured":"A. Martin, M. Nakashima, A. Zhou, D. Aronson, A.J. Werner, T.F. Davies, Detection of major T cell epitopes on human thyroid stimulating hormone receptor by overriding immune heterogeneity in patients with Graves\u2019 disease. J. Clin. Endocrinol. Metab. 82(10), 3361\u20133366 (1997). https:\/\/doi.org\/10.1210\/jcem.82.10.4299","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"4","key":"2770_CR35","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1038\/ni1178","volume":"6","author":"S Sakaguchi","year":"2005","unstructured":"S. Sakaguchi, Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self. Nat. Immunol. 6(4), 345\u2013352 (2005). https:\/\/doi.org\/10.1038\/ni1178","journal-title":"Nat. Immunol."},{"issue":"7090","key":"2770_CR36","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1038\/nature04753","volume":"441","author":"E Bettelli","year":"2006","unstructured":"E. Bettelli, Y. Carrier, W. Gao, T. Korn, T.B. Strom, M. Oukka, H.L. Weiner, V.K. Kuchroo, Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 441(7090), 235\u2013238 (2006). https:\/\/doi.org\/10.1038\/nature04753","journal-title":"Nature"},{"issue":"6","key":"2770_CR37","doi-asserted-by":"publisher","first-page":"2593","DOI":"10.1084\/jem.183.6.2593","volume":"183","author":"F Fossiez","year":"1996","unstructured":"F. Fossiez, O. Djossou, P. Chomarat, L. Flores-Romo, S. Ait-Yahia, C. Maat, J.J. Pin, P. Garrone, E. Garcia, S. Saeland, D. Blanchard, C. Gaillard, B. Das Mahapatra, E. Rouvier, P. Golstein, J. Banchereau, S. Lebecque, T cell interleukin-17 induces stromal cells to produce proinflammatory and hematopoietic cytokines. J. Exp. Med. 183(6), 2593\u20135603 (1996). https:\/\/doi.org\/10.1084\/jem.183.6.2593","journal-title":"J. Exp. Med."},{"issue":"2","key":"2770_CR38","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1007\/BF02684010","volume":"51","author":"E Lubberts","year":"2002","unstructured":"E. Lubberts, L.A. Joosten, F.A. van de Loo, P. Schwarzenberger, J. Kolls, W.B. van den Berg, Overexpression of IL-17 in the knee joint of collagen type II immunized mice promotes collagen arthritis and aggravates joint destruction. Inflamm. Res. 51(2), 102\u2013104 (2002). https:\/\/doi.org\/10.1007\/BF02684010","journal-title":"Inflamm. Res."},{"issue":"1","key":"2770_CR39","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1111\/j.1365-2249.2007.03356.x","volume":"148","author":"B Afzali","year":"2007","unstructured":"B. Afzali, G. Lombardi, R.I. Lechler, G.M. Lord, The role of T helper 17 (Th17) and regulatory T cells (Treg) in human organ transplantation and autoimmune disease. Clin. Exp. Immunol. 148(1), 32\u201346 (2007). https:\/\/doi.org\/10.1111\/j.1365-2249.2007.03356.x","journal-title":"Clin. Exp. Immunol."},{"issue":"3","key":"2770_CR40","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.autrev.2007.11.005","volume":"7","author":"T Bohgaki","year":"2008","unstructured":"T. Bohgaki, T. Atsumi, T. Koike, Autoimmune disease after autologous hematopoietic stem cell transplantation. Autoimmun. Rev. 7(3), 198\u2013203 (2008). https:\/\/doi.org\/10.1016\/j.autrev.2007.11.005","journal-title":"Autoimmun. Rev."},{"issue":"26","key":"2770_CR41","doi-asserted-by":"publisher","first-page":"2734","DOI":"10.1056\/NEJMc076383","volume":"357","author":"T Bohgaki","year":"2007","unstructured":"T. Bohgaki, T. Atsumi, T. Koike, Multiple autoimmune diseases after autologous stem-cell transplantation. N. Engl. J. Med. 357(26), 2734\u20132736 (2007). https:\/\/doi.org\/10.1056\/NEJMc076383","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"2770_CR42","doi-asserted-by":"publisher","first-page":"R59","DOI":"10.1530\/EC-19-0543","volume":"9","author":"ML Barreto-Chaves","year":"2020","unstructured":"M.L. Barreto-Chaves, N. Senger, M. Fevereiro, A.C. Parletta, A. Takano, Impact of hyperthyroidism on cardiac hypertrophy. Endocr. Connect 9(3), R59\u2013R69 (2020). https:\/\/doi.org\/10.1530\/EC-19-0543","journal-title":"Endocr. Connect"},{"issue":"4","key":"2770_CR43","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1177\/1753944715623228","volume":"10","author":"GP Diniz","year":"2016","unstructured":"G.P. Diniz, N. Senger, M.S. Carneiro-Ramos, R.A. Santos, M.L. Barreto-Chaves, Cardiac ACE2\/angiotensin 1-7\/Mas receptor axis is activated in thyroid hormone-induced cardiac hypertrophy. Ther. Adv. Cardiovasc. Dis. 10(4), 192\u2013202 (2016). https:\/\/doi.org\/10.1177\/1753944715623228","journal-title":"Ther. Adv. Cardiovasc. Dis."},{"issue":"6485","key":"2770_CR44","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1126\/science.abb2762","volume":"367","author":"R Yan","year":"2020","unstructured":"R. Yan, Y. Zhang, Y. Li, L. Xia, Y. Guo, Q. Zhou, Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2. Science 367(6485), 1444\u20131448 (2020). https:\/\/doi.org\/10.1126\/science.abb2762","journal-title":"Science"},{"issue":"7","key":"2770_CR45","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1001\/jamacardio.2020.1282","volume":"5","author":"C Bavishi","year":"2020","unstructured":"C. Bavishi, T.M. Maddox, F.H. Messerli, Coronavirus disease 2019 (COVID-19) infection and renin angiotensin system blockers. JAMA Cardiol. 5(7), 745\u2013747 (2020). https:\/\/doi.org\/10.1001\/jamacardio.2020.1282","journal-title":"JAMA Cardiol."},{"issue":"3","key":"2770_CR46","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1177\/0004563220922255","volume":"57","author":"G Lippi","year":"2020","unstructured":"G. Lippi, A.M. South, B.M. Henry, Electrolyte imbalances in patients with severe coronavirus disease 2019 (COVID-19). Ann. Clin. Biochem. 57(3), 262\u2013265 (2020). https:\/\/doi.org\/10.1177\/0004563220922255","journal-title":"Ann. Clin. Biochem."},{"issue":"11","key":"2770_CR47","doi-asserted-by":"publisher","first-page":"e11305","DOI":"10.7759\/cureus.11305","volume":"12","author":"S Pastor","year":"2020","unstructured":"S. Pastor, \u00c1. Sr. Molina, E. De Celis, Thyrotoxic Crisis and COVID-19 Infection: An Extraordinary Case and Literature Review. Cureus 12(11), e11305 (2020). https:\/\/doi.org\/10.7759\/cureus.11305","journal-title":"Cureus"},{"issue":"2","key":"2770_CR48","doi-asserted-by":"publisher","first-page":"182","DOI":"10.4158\/EP14023.OR","volume":"21","author":"S Swee du","year":"2015","unstructured":"S. Swee du, C.L. Chng, A. Lim, Clinical characteristics and outcome of thyroid storm: a case series and review of neuropsychiatric derangements in thyrotoxicosis. Endocr. Pract. 21(2), 182\u2013189 (2015). https:\/\/doi.org\/10.4158\/EP14023.OR","journal-title":"Endocr. Pract."},{"issue":"1","key":"2770_CR49","doi-asserted-by":"publisher","first-page":"G33","DOI":"10.1530\/EJE-20-0445","volume":"183","author":"K Boelaert","year":"2020","unstructured":"K. Boelaert, W.E. Visser, P.N. Taylor, C. Moran, J. L\u00e9ger, L. Persani, ENDOCRINOLOGY IN THE TIME OF COVID-19: management of hyperthyroidism and hypothyroidism. Eur. J. Endocrinol. 183(1), G33\u2013G39 (2020). https:\/\/doi.org\/10.1530\/EJE-20-0445","journal-title":"Eur. J. Endocrinol."},{"key":"2770_CR50","doi-asserted-by":"publisher","first-page":"100448","DOI":"10.1016\/j.eclinm.2020.100448","volume":"24","author":"S Almazeedi","year":"2020","unstructured":"S. Almazeedi, S. Al-Youha, M.H. Jamal, M. Al-Haddad, A. Al-Muhaini, F. Al-Ghimlas, S. Al-Sabah, Characteristics, risk factors and outcomes among the first consecutive 1096 patients diagnosed with COVID-19 in Kuwait. EClinicalMedicine 24, 100448 (2020). https:\/\/doi.org\/10.1016\/j.eclinm.2020.100448","journal-title":"EClinicalMedicine"},{"key":"2770_CR51","doi-asserted-by":"publisher","unstructured":"M. Cao, D. Zhang, Y. Wang, Y. Lu, X. Zhu, Y. Li, H. Xue, Y. Lin, M. Zhang, Y. Sun, Z. Yang, J. Shi, Y. Wang, C. Zhou, Y. Dong, P. Liu, S. M. Dudek, Z. Xiao, H. Lu, L. Peng, Clinical features of patients infected with the 2019 novel coronavirus (COVID-19) in Shanghai, China. medRxiv. 2020;2020.03.04.20030395. https:\/\/doi.org\/10.1101\/2020.03.04.20030395.","DOI":"10.1101\/2020.03.04.20030395"},{"key":"2770_CR52","doi-asserted-by":"publisher","DOI":"10.1038\/srep22271","volume":"6","author":"J Liu","year":"2016","unstructured":"J. Liu, X. Wu, F. Lu, L. Zhao, L. Shi, F. Xu, Low T3 syndrome is a strong predictor of poor outcomes in patients with community-acquired pneumonia. Sci. Rep. 6, 22271 (2016). https:\/\/doi.org\/10.1038\/srep22271","journal-title":"Sci. Rep."},{"issue":"8","key":"2770_CR53","doi-asserted-by":"publisher","first-page":"e0237130","DOI":"10.1371\/journal.pone.0237130","volume":"15","author":"M Shabrawishi","year":"2020","unstructured":"M. Shabrawishi, M.M. Al-Gethamy, A.Y. Naser, M.A. Ghazawi, G.F. Alsharif, E.F. Obaid, H.A. Melebari, D.M. Alamri, A.S. Brinji, F.H. Al Jehani, W. Almaimani, R.A. Ekram, K.H. Alkhatib, H. Alwafi, Clinical, radiological and therapeutic characteristics of patients with COVID-19 in Saudi Arabia. PLoS One 15(8), e0237130 (2020). https:\/\/doi.org\/10.1371\/journal.pone.0237130","journal-title":"PLoS One"},{"issue":"8","key":"2770_CR54","doi-asserted-by":"publisher","first-page":"e0237960","DOI":"10.1371\/journal.pone.0237960","volume":"15","author":"A Sis\u00f3-Almirall","year":"2020","unstructured":"A. Sis\u00f3-Almirall, B. Kostov, M. Mas-Heredia, S. Vilanova-Rotllan, E. Sequeira-Aymar, M. Sans-Corrales, E. Sant-Arderiu, L. Cayuelas-Redondo, A. Mart\u00ednez-P\u00e9rez, N. Garc\u00eda-Plana, A. Anguita-Guimet, J. Benavent-\u00c0reu, Prognostic factors in Spanish COVID-19 patients: a case series from Barcelona. PLoS One 15(8), e0237960 (2020). https:\/\/doi.org\/10.1371\/journal.pone.0237960","journal-title":"PLoS One"},{"issue":"11","key":"2770_CR55","doi-asserted-by":"publisher","first-page":"1770","DOI":"10.1093\/infdis\/jiaa119","volume":"221","author":"Y Wang","year":"2020","unstructured":"Y. Wang, Y. Liu, L. Liu, X. Wang, N. Luo, L. Li, Clinical outcomes in 55 patients with severe acute respiratory syndrome coronavirus 2 who were asymptomatic at hospital admission in Shenzhen, China. J. Infect. Dis. 221(11), 1770\u20131774 (2020). https:\/\/doi.org\/10.1093\/infdis\/jiaa119","journal-title":"J. Infect. Dis."},{"key":"2770_CR56","doi-asserted-by":"publisher","unstructured":"S. Yan, X. Song, F. Lin, H. Zhu, X. Wang, M. Li, J. Ruan, C. Lin, X. Liu, Q. Wu, Z. Luo, W. Fu, S. Chen, Y. Yuan, S. Liu, J. Yao, C. Lv, Clinical characteristics of coronavirus disease 2019 in Hainan, China. medRxiv (2020), https:\/\/doi.org\/10.1101\/2020.03.19.20038539.","DOI":"10.1101\/2020.03.19.20038539"},{"issue":"7","key":"2770_CR57","doi-asserted-by":"publisher","first-page":"1730","DOI":"10.1111\/all.14238","volume":"75","author":"JJ Zhang","year":"2020","unstructured":"J.J. Zhang, X. Dong, Y.Y. Cao, Y.D. Yuan, Y.B. Yang, Y.Q. Yan, C.A. Akdis, Y.D. Gao, Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China. Allergy 75(7), 1730\u20131741 (2020). https:\/\/doi.org\/10.1111\/all.14238","journal-title":"Allergy"},{"issue":"5","key":"2770_CR58","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1016\/j.dsx.2020.07.044","volume":"14","author":"TI Hariyanto","year":"2020","unstructured":"T.I. Hariyanto, A. Kurniawan, Thyroid disease is associated with severe coronavirus disease 2019 (COVID-19) infection. Diabetes Metab. Syndr. 14(5), 1429\u20131430 (2020). https:\/\/doi.org\/10.1016\/j.dsx.2020.07.044","journal-title":"Diabetes Metab. Syndr."},{"key":"2770_CR59","doi-asserted-by":"publisher","first-page":"350","DOI":"10.3389\/fendo.2019.00350","volume":"10","author":"MDM Montesinos","year":"2019","unstructured":"M.D.M. Montesinos, C.G. Pellizas, Thyroid hormone action on innate immunity. Front Endocrinol. (Lausanne) 10, 350 (2019). https:\/\/doi.org\/10.3389\/fendo.2019.00350","journal-title":"Front Endocrinol. (Lausanne)"},{"issue":"6","key":"2770_CR60","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1016\/j.chom.2020.05.009","volume":"27","author":"JL McKechnie","year":"2020","unstructured":"J.L. McKechnie, C.A. Blish, The innate immune system: fighting on the front lines or fanning the flames of COVID-19? Cell Host Microbe 27(6), 863\u2013869 (2020). https:\/\/doi.org\/10.1016\/j.chom.2020.05.009","journal-title":"Cell Host Microbe"},{"issue":"2","key":"2770_CR61","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1210\/jc.2009-1719","volume":"95","author":"N Figueroa-Vega","year":"2010","unstructured":"N. Figueroa-Vega, M. Alfonso-P\u00e9rez, I. Benedicto, F. S\u00e1nchez-Madrid, R. Gonz\u00e1lez-Amaro, M. Marazuela, Increased circulating pro-inflammatory cytokines and Th17 lymphocytes in Hashimoto\u2019s thyroiditis. J. Clin. Endocrinol. Metab. 95(2), 953\u2013962 (2010). https:\/\/doi.org\/10.1210\/jc.2009-1719","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"20","key":"2770_CR62","first-page":"4680","volume":"21","author":"LF Lv","year":"2017","unstructured":"L.F. Lv, H.Y. Jia, H.F. Zhang, Y.X. Hu, Expression level and clinical significance of IL-2, IL-6 and TGF-\u03b2 in elderly patients with goiter and hyperthyroidism. Eur. Rev. Med. Pharmacol. Sci. 21(20), 4680\u20134686 (2017)","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"issue":"1","key":"2770_CR63","doi-asserted-by":"publisher","first-page":"e13","DOI":"10.1016\/j.jinf.2020.03.062","volume":"81","author":"Z Yang","year":"2020","unstructured":"Z. Yang, J. Liu, Y. Zhou, X. Zhao, Q. Zhao, J. Liu, The effect of corticosteroid treatment on patients with coronavirus infection: a systematic review and meta-analysis. J. Infect. 81(1), e13\u2013e20 (2020). https:\/\/doi.org\/10.1016\/j.jinf.2020.03.062","journal-title":"J. Infect."},{"key":"2770_CR64","doi-asserted-by":"publisher","first-page":"102382","DOI":"10.1016\/j.jaut.2019.102382","volume":"110","author":"V Saferding","year":"2020","unstructured":"V. Saferding, S. Bl\u00fcml, Innate immunity as the trigger of systemic autoimmune diseases. J. Autoimmun. 110, 102382 (2020). https:\/\/doi.org\/10.1016\/j.jaut.2019.102382","journal-title":"J. Autoimmun."},{"key":"2770_CR65","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.2147\/IJGM.S261433","volume":"13","author":"R El Sabbagh","year":"2020","unstructured":"R. El Sabbagh, N.S. Azar, A.A. Eid, S.T. Azar, Thyroid dysfunctions due to immune checkpoint inhibitors: a review. Int J. Gen. Med 13, 1003\u20131009 (2020). https:\/\/doi.org\/10.2147\/IJGM.S261433","journal-title":"Int J. Gen. Med"},{"issue":"1","key":"2770_CR66","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/s12026-016-8819-5","volume":"65","author":"JT Ruiz","year":"2017","unstructured":"J.T. Ruiz, L. Luj\u00e1n, M. Blank, Y. Shoenfeld, Adjuvants- and vaccines-induced autoimmunity: animal models. Immunol. Res 65(1), 55\u201365 (2017). https:\/\/doi.org\/10.1007\/s12026-016-8819-5","journal-title":"Immunol. Res"},{"key":"2770_CR67","doi-asserted-by":"publisher","unstructured":"O. Vera-Lastra, A. Ordinola Navarro, M. P. Cruz Domiguez, G. Medina, T. I. S\u00e1nchez Valadez, L. J. Jara, Two cases of Graves\u2019 disease following SARS-CoV-2 vaccination: an autoimmune\/inflammatory syndrome induced by adjuvants. Thyroid. (2021). https:\/\/doi.org\/10.1089\/thy.2021.0142.","DOI":"10.1089\/thy.2021.0142"},{"issue":"3","key":"2770_CR68","doi-asserted-by":"publisher","first-page":"e106","DOI":"10.1016\/j.bja.2020.12.020","volume":"126","author":"LH Garvey","year":"2021","unstructured":"L.H. Garvey, S. Nasser, Anaphylaxis to the first COVID-19 vaccine: is polyethylene glycol (PEG) the culprit? Br. J. Anaesth. 126(3), e106\u2013e108 (2021). https:\/\/doi.org\/10.1016\/j.bja.2020.12.020","journal-title":"Br. J. Anaesth."},{"issue":"4","key":"2770_CR69","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1159\/000501824","volume":"8","author":"A Brancatella","year":"2019","unstructured":"A. Brancatella, N. Viola, S. Brogioni, L. Montanelli, C. Sardella, P. Vitti, C. Marcocci, I. Lupi, F. Latrofa, Graves\u2019 disease induced by immune checkpoint inhibitors: a case report and review of the literature. Eur. Thyroid J. 8(4), 192\u2013195 (2019). https:\/\/doi.org\/10.1159\/000501824","journal-title":"Eur. Thyroid J."}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-021-02770-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12020-021-02770-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-021-02770-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,7]],"date-time":"2021-07-07T18:44:05Z","timestamp":1625683445000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12020-021-02770-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,9]]},"references-count":69,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["2770"],"URL":"https:\/\/doi.org\/10.1007\/s12020-021-02770-6","relation":{},"ISSN":["1355-008X","1559-0100"],"issn-type":[{"value":"1355-008X","type":"print"},{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,9]]},"assertion":[{"value":"5 April 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 May 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. This review article does not contain\/report any primary data from humans or animals.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}